![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2023/08/SaluTech.png)
SaluTech
SaluTech is developing a safe Conductive Biomaterial (CBM) to treat Atrial Fibrillation by resynchronizing the electrical propagation in the heart.
SaluTech is developing a safe Conductive Biomaterial (CBM) to treat Atrial Fibrillation by resynchronizing the electrical propagation in the heart.